Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Mendel.ai is an artificial intelligence company dedicated to transforming how medical data is understood and utilized. Their core technology acts like a 'machine that can read and understand medicine,' capable of sifting through vast amounts of unstructured clinical data from electronic health records and medical literature. For end-users like researchers, pharmaceutical companies, and healthcare providers, Mendel.ai offers solutions to accelerate clinical trial recruitment, generate real-world evidence, identify therapeutic targets, and ultimately, to help clinicians make more informed decisions. Their mission is to make sense of the world's medical knowledge to improve patient outcomes and advance medical science.
The San Jose headquarters serves as the primary hub for research and development, engineering, product management, corporate strategy, sales, marketing, and administrative functions.
Situated in a prominent Silicon Valley tech corridor, the headquarters likely features modern office amenities, collaborative workspaces, and advanced technology infrastructure conducive to AI development and innovation.
Mendel.ai fosters a mission-driven, innovative, and collaborative work culture. The environment encourages continuous learning, problem-solving, and teamwork, with a strong focus on making a significant impact in the healthcare industry through artificial intelligence.
Its location in Silicon Valley is strategically important, providing Mendel.ai with access to a rich talent pool in AI and software engineering, proximity to technological advancements, venture capital, and a vibrant ecosystem of healthcare and technology partners.
While its primary headquarters is in San Jose, CA, Mendel.ai supports a distributed team with members across North America, Europe, and the Middle East. Their AI-powered solutions for clinical data abstraction and analysis are designed for global applicability, supporting pharmaceutical companies, research institutions, and healthcare organizations worldwide in their efforts to advance medical research and improve patient care. Their technology can process and understand medical information irrespective of geographical origin, enabling global clinical trials and real-world evidence studies.
1735 N 1st St
San Jose
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Mendel.ai' leadership includes:
Mendel.ai has been backed by several prominent investors over the years, including:
Over the past 12-18 months, Mendel.ai has strategically strengthened its leadership team, particularly in commercial and product areas, to drive growth and market expansion. Key appointments include experienced executives to lead revenue generation and product strategy. No major C-suite departures have been publicly announced during this period.
Discover the tools Mendel.ai uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Mendel.ai likely uses common professional email formats. While the exact structure isn't publicly confirmed for all employees, patterns observed for similar tech companies often include [first name]@[company_domain] or [first initial][last name]@[company_domain].
Common formats include [first]@mendel.ai and [first].[last]@mendel.ai
Format
karim@mendel.ai
Example
75%
Success rate
Business Wire • May 9, 2024
Mendel announced the launch of Hypercube, its advanced AI solution designed to deeply interrogate clinical data from various sources. This new offering aims to provide researchers and clinicians with richer insights, enabling more precise real-world evidence generation and accelerated drug development pipelines....more
Business Wire • November 2, 2023
Mendel.ai partnered with Syneos Health to integrate its AI-powered technology into Syneos Health's clinical development processes. The collaboration aims to enhance patient matching for clinical trials, streamline data abstraction, and accelerate the overall drug development lifecycle by leveraging Mendel's AI capabilities....more
PR Newswire • February 15, 2022
Mendel.ai announced a $40 million Series B funding round led by Oak HC/FT, with participation from existing investors. The funding is intended to scale its AI platform, expand its team, and further develop its technology to help researchers unlock insights from clinical data more efficiently....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Mendel.ai, are just a search away.